Vitexin inhibits Aß25-35 induced toxicity in Neuro-2a cells by augmenting Nrf-2/HO-1 dependent antioxidant pathway and regulating lipid homeostasis by the activation of LXR-a

• Published in: Toxicology in vitro Vol. 50; p. 160
• Main Authors: Malar, Dicson Sheeja, Suryanarayanan, Venkatesan, Prasanth, Mani Iyer, Singh, Sanjeev Kumar, Balamurugan, Krishnaswamy, Devi, Kasi Pandima
• Format: Journal Article
• Language: English
• Published: Oxford Elsevier Science Ltd 01.08.2018
• Subjects: Activation; Alzheimer's disease; Antioxidants; Apolipoprotein E; Apoptosis; Bax protein; Caspase; Caspase-3; Chemical compounds; Cholesterol; CHOP protein; Endoplasmic reticulum; Free radicals; GA-binding protein; Gene expression; Homeostasis; Lipid metabolism; Lipid peroxidation; Lipids; Membrane potential; Metabolism; Neurodegenerative diseases; Neuroprotection; Oxidation; Peroxidation; Pretreatment; Proteins; Reactive oxygen species; Signal transduction; Toxicity
• ISSN: 0887-2333; 1879-3177

Amyloid beta (Aβ) formation is one of the neuropathological hallmarks of Alzheimer's disease (AD), which induces the generation of reactive oxygen species (ROS), further leading to the alteration of several signalling pathways. In the present study, vitexin has been evaluated for its neuroprotective activity against Aβ25-35 induced toxicity in Neuro-2a cells. Results of cell free studies indicated that vitexin significantly inhibited the aggregation of Aβ25-35. Studies in Neuro-2a cells revealed that Aβ25-35 significantly affected the cell viability by inducing ROS mediated toxicity and apoptosis. However, pre-treatment of Neuro-2a cells with vitexin (50 μM) significantly restored the cell viability up to 92.86 ± 5.57%. Vitexin has been found to inhibit the production of free radicals and suppress ROS mediated lipid peroxidation, protein oxidation and loss of membrane potential. Also, vitexin modulated the expression of genes involved in antioxidant response mechanisms (Nrf-2, HO-1), cholesterol metabolism (LXR-α, APOE, ABCA-1, Seladin-1), and endoplasmic reticulum stress (Grp78, Gadd153) to offer neuroprotection. Aβ25-35 induced caspase-3 activation, and Bax protein expression was also found to be significantly inhibited by vitexin. Taken together, our results indicate that vitexin offers neuroprotection to cells in part via augmenting the antioxidant mechanisms, maintaining lipid homeostasis and inhibiting apoptosis induced by Aβ.